Evidence map›Paper›PMID 29108365›Full record

ArticleOncotarget2017

A 3-year observation of testosterone deficiency in Chinese patients with chronic heart failure.

Ying Han, Weiju Sun, Guizhi Sun, Xiaolu Hou, Zhaowei Gong, Jing Xu, Xiuping Bai, Lu Fu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ying HanCardiovascular Department, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Weiju SunCardiovascular Department, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Guizhi SunCardiovascular Department, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Xiaolu HouCardiovascular Department, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Zhaowei GongCardiovascular Department, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Jing XuCardiovascular Department, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Xiuping BaiCardiovascular Department, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Lu FuCardiovascular Department, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Harbin Medical University · CNFourth Affiliated Hospital of Harbin Medical University · CNFirst Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Testosterone deficiency is present in a certain proportion men with chronic heart failure (CHF). Low testosterone levels in American and European patients with CHF lead to the high mortality and readmission rates. Interestingly, this relationship has not been studied in Chinese patients. To this end, 167 Chinese men with CHF underwent clinical and laboratory evaluations associated with determinations of testosterone levels. Total testosterone (TT) levels and sex hormone-binding globulin were measured by chemiluminescence or immunoassays assays and free testosterone (FT) levels were calculated, Based upon results from these assays, patients were divided into either a low testosterone (LT;

Indexed as

chronic heart failuremortalityreadmissiontestosterone deficiency

Identifiers

PMID29108365
PMCPMC5668098
OpenAlexW2741728035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.